Furthermore, in diabetic and obese mice, the administration of atorvastatin and ezetimibe, one reducing cholesterol production and the other its uptake by HMGCR inhibition and the Niemann–Pick C1-like 1 (NPC1L1) proteins, significantly reversed liver fibrosis of MASH mice [87]. Here, NPC1L1 is linked to Hepatic fibrosis.